/Companies

Kiffik Biomedical

Providence, US · Founded 2021 · Delaware corporation

Find your way into Kiffik Biomedical

Sign up to see every warm intro you have to Kiffik Biomedical

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Kiffik Biomedical team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

KIFFIK develops a platform with proprietary K-EXP™ technology to enable direct access to interstitial fluid for biomarker discovery, drug development, and disease monitoring across oncology, neurology, metabolic conditions, and veterinary health.

Founders & leadership

GCGeorge Cagna
George CagnaPresident and Chief Executive OfficerGeorge Cagna is CEO of Kiffik Biomedical, which develops a platform using proprietary K-EXP™ technology to enable access to interstitial fluid for biomarker discovery and drug development. He brings over 35 years of leadership experience in medical devices and life sciences, including senior roles at Medtronic and Boston Scientific, with expertise in product strategy, regulatory affairs, manufacturing, and R&D.
NM
Nicholas MarrChief Operation Officer
HP
Howard PetersonChief Commercial Officer and Board Secretary

Board

BD
Brian DouganChairman of the Board
BC
Blake CarverBoard Member

Funding

SEC filings, press & company announcements

$830K disclosed across 1 of 2 rounds · 2021–2025

▶$830KraisedJun 2022 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • George CagnaExecutive Officer, Director, Promoter
  • Brian DouganExecutive Officer, Director, Promoter
  • Nicholas MarrExecutive Officer, Director, Promoter
  • Blake CarverDirector
  • Howard PetersonExecutive Officer, Director
Offering amount
$15M
Amount sold
$830K
Minimum investment
$10K
First sale
Sep 2021
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 4

Companies working in the same space as Kiffik Biomedical.

Frequently asked questions

What does Kiffik Biomedical do?
KIFFIK develops a platform with proprietary K-EXP™ technology to enable direct access to interstitial fluid for biomarker discovery, drug development, and disease monitoring across oncology, neurology, metabolic conditions, and veterinary health.
How much funding has Kiffik Biomedical raised?
Kiffik Biomedical has disclosed $830K raised across 1 of its 2 known rounds.
Where is Kiffik Biomedical headquartered?
Kiffik Biomedical is headquartered in Providence, US.